Second-look surgery for colorectal cancer. The second time around

Area of Science:

• Oncology
• Surgical Oncology
• Nuclear Medicine

Background:

• Colorectal cancer recurrence often necessitates second-look surgical procedures.
• Accurate patient selection for resectability is crucial for improving outcomes in recurrent disease.
• Traditional surgical exploration methods may have limitations in detecting all sites of tumor recurrence.

Purpose of the Study:

• To evaluate the impact of Radioimmunoguided Surgery (RIGS) on patient selection and survival in colorectal cancer patients undergoing second-look surgery.
• To compare the efficacy of RIGS with traditional palpation and inspection methods in identifying resectable disease.
• To assess long-term survival rates based on RIGS-guided resectability.

Main Methods:

• Eighty-six colorectal cancer patients underwent second-look surgery within a RIGS protocol.
• Patients received a radiolabeled B72.3 monoclonal antibody (iodine-125) for intraoperative detection.
• Handheld gamma-detecting probes (Neoprobe 1000) monitored biologic clearance and guided surgical exploration.
• Surgical plans were compared before and after RIGS exploration.

Main Results:

• RIGS identified fewer resectable patients (47%) compared to traditional methods (62%), but these were more accurately selected.
• Survival rates at 5 years were 60% for RIGS-resectable patients versus 0% for non-resectable groups.
• RIGS use was associated with improved accurate selection of resectable patients, leading to better survival.

Conclusions:

• Radioimmunoguided Surgery significantly enhances the accurate selection of resectable patients for second-look procedures in recurrent colorectal cancer.
• The improved patient selection facilitated by RIGS directly correlates with improved long-term survival outcomes.
• RIGS offers a valuable adjunct to traditional surgical techniques for optimizing treatment strategies in recurrent colorectal cancer.